Who owns Infinity Pharmaceuticals?

Key details on Infinity Pharmaceuticals (Ticker: INFI)

Who owns Infinity Pharmaceuticals?

Is INFI a good stock to own? Find out who bought Infinity Pharmaceuticals, who sold Infinity Pharmaceuticals (INFI) stock, and who holds a large position in Infinity Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 5.59M $61.25M June 30, 2015
Vanguard 5.46M $59.75M June 30, 2015
OrbiMed Advisors 4.26M $59.62M March 31, 2015
Deerfield Management Company 3.97M $55.47M March 31, 2015
S.A.C. Capital Advisors 3.41M $40.56M March 31, 2014
STATE STREET CORPORATION 3.26M $35.65M June 30, 2015
Perceptive Advisors 3.25M $157.49M March 31, 2013
Quogue Capital 2.91M $101.68M Dec. 31, 2012
BlackRock Fund Advisors 2.81M $30.80M June 30, 2015
BB Biotech AG 2.70M $29.57M June 30, 2015
Point72 Asset Management 2.20M $29.52M Sept. 30, 2014
BVF 2.18M $19.31M Dec. 31, 2011
FMR 2.16M $23.70M June 30, 2015
Wellington Management Company 2.02M $22.17M June 30, 2015
Broadfin Capital 1.44M $425.27M June 30, 2014
BlackRock Institutional Trust Company, N.A. 1.42M $15.56M June 30, 2015
QVT Financial 1.33M $23.12M Sept. 30, 2013
SUSQUEHANNA INTERNATIONAL 1.29M $17.80M Dec. 31, 2013
Consonance Capital 1.26M $15.01M March 31, 2014
Acadian Asset Management 1.25M $13.70M June 30, 2015
Millennium Management 1.24M $20.96M Dec. 31, 2014
BlackRock Advisors 1.17M $20.36M Sept. 30, 2013
Dr. Jeffrey R. Jay, M.D. 1.10M $14.76M Sept. 30, 2014
NUMERIC INVESTORS 1.08M $11.77M June 30, 2015
Baker Bros. Advisors 1.02M $16.46M June 30, 2013
Ameriprise Financial 968283 $16.90M Sept. 30, 2013
Visium Asset Management 951852 $13.15M Dec. 31, 2013
HealthCor Management 923600 $11.77M June 30, 2014
T. Rowe Price Associates 892070 $15.07M Dec. 31, 2014